National Vaccine
Information Center

Your Health. Your Family. Your Choice.
Search Results

From the 1/7/2022 release of VAERS data:

This is VAERS ID 368528

Government Disclaimer on use of this data

Case Details

VAERS ID: 368528 (history)  
Form: Version 1.0  
Age: 19.0  
Sex: Female  
Location: Foreign  
   Days after vaccination:1
Submitted: 2009-11-18
   Days after onset:244
Entered: 2009-11-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route

Administered by: Other       Purchased by: Other
Symptoms: Headache, Lumbar puncture normal, Neurological examination normal, Nuclear magnetic resonance imaging brain normal, Photophobia
SMQs:, Noninfectious meningitis (narrow), Glaucoma (broad), Corneal disorders (broad), Retinal disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 0 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Microgynon (Ethinyloestradiol + Levonorgestrel)
Current Illness: Unknown
Preexisting Conditions: Asthma
Diagnostic Lab Data: Lumbar puncture, normal; MRI brain, normal
CDC Split Type: B0603413A

Write-up: This case was reported by a foreign agency (Agency # GB-MHRA-ADR-20522503) and described the occurrence of severe headaches in a 19-year-old female subject who was vaccinated with CERVARIX, GlaxoSmithKline. The subject''s medical history included asthma. Concurrent medications included MICROGYNON. On 18 March 2009, the subject received a single dose of CERVARIX (intramuscular, batch number: AHPVA057AA). On 19 March 2009, 1 day after the vaccination with CERVARIX, the subject experienced headache and photophobia. The subject was hospitalised. Relevant test results included a lumbar puncture and a brain MRI which were both normal. The Neurological review was reported as normal. Approximately 20 days later, the headache had improved but had not yet resolved. At the time of reporting the events were unresolved. Verbatim Text: Severe headache, admitted to hospital as associated photophobia. Medically significant: 20 days later headache lessened but continues with headache. Neurological review normal.

New Search

Link To This Search Result:

Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166